Navigation Links
Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
Date:3/12/2009

II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.S. Phase 2 combination REOLYSIN(R)/paclitaxel and carboplatin clinical trial for patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the tolerability of REOLYSIN(R) outside a controlled test, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
2. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
3. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
4. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
5. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
6. Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
7. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
8. AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne
9. AMA Foundation Announces Seed Grant Research Recipients
10. Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
11. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... KONG , July 28, 2014  Syneron Medical ... aesthetic device company, announced today that its new PicoWay® ... of all types and colors and pigmented lesions on ... dual wavelength device, with 532nm and 1064nm wavelengths, which ... the skin using pulses which are trillionths of a ...
(Date:7/28/2014)... ResMed (NYSE: RMD ), innovatore ... dei disturbi respiratori del sonno (SDB) e altre patologie ... Germania contro il produttore Taiwanese di dispositivi medicali, APEX ... da indossare in testa, che violano i brevetti, utilizzate ... sentenza della Corte Regionale Distrettuale di Monaco ...
(Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, ... Roger Crystal , MD as Vice President of ... Global Business Development Product Acquisition & Licensing team at ... developing business strategy and partnerships in the precision medicine ... partner with biotechnology and pharmaceutical companies across the spectrum ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2
...   Sigma-Aldrich ® Corporation (Nasdaq: SIAL ... Employers by the Corporate Research Foundation (CRF) Institute, ... associations, researchers and international publishers that offers independent ... one of nine companies that earned Top Employer ...
...  Nephros, Inc. (OTC Bulletin Board: NEPH ), ... for therapeutic applications, infection control, and water purification, announced ... year ended December 31, 2011. 2011 ... , Increased ultrafiltration product revenues  to approximately $618,000, ...
Cached Medicine Technology:CRF Institute Names Sigma-Aldrich Top Employer Europe 2012 2CRF Institute Names Sigma-Aldrich Top Employer Europe 2012 3Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 2Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 3Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 4Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 5Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 6Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 7Nephros Reports 2011 Fourth Quarter and Full Year Financial Results 8
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
(Date:7/28/2014)... Washington, DC (PRWEB) July 28, 2014 ... recipe app for iOS, App is available on iTunes for ... first of its kind, Audio Chef allows you to listen ... gourmet cuisine the easy way: simply get out the ingredients ... no need to measure or prepare ingredients ahead of time, ...
(Date:7/28/2014)... meal you,ve ordered at a restaurantor when something ... your brain. , These waves are called ... cellsboth excitatory and inhibitoryplaying together in an orchestrated ... waves have been associated with higher-level brain function, ... to schizophrenia, Alzheimer,s disease, autism, epilepsy and other ...
(Date:7/28/2014)... 28, 2014 UT Southwestern Medical Center cancer ... irreversibly interferes with the activity of a mutated ... , The molecule, SML-8-73-1 (SML), interferes with the ... homolog. The gene produces proteins called K-Ras that ... result in normal cells dividing uncontrollably and turning ...
(Date:7/28/2014)... 2014 The report, “Blowing Agents ... - Trends and Forecasts to 2019” defines and ... and forecasting of the global consumption volume and ... tables with 39 figures spread through 226 Pages ... http://www.marketsandmarkets.com/Market-Reports/blowing-agents-market-71329121.html , Blowing agents are highly utilized ...
Breaking Medicine News(10 mins):Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4
... debate is still on. Is Hormone Replacement Therapy (HRT), good ... caution. The treatment, which targets menopausal women by giving them ... two -edged sword. Its risks such as breast cancer, and ... traumatic menopausal symptoms. This was mainly due to a 2002 ...
... have criticized Prime Minister John Howard for calling for a ... there was no evidence to suggest migrants were responsible for ... Minister Howard had made the suggestion in an interview to ... sharp rise in HIV cases. ,Don Baxter, ...
... forces to perfect a powerful new weapon in the war ... spores. //Their results are published in the prestigious journal Science, ... to use lasers to detect anthrax in real time as ... now,” says Marlan Scully, Distinguished Professor of Physics at Texas ...
... sexually transmitted disease, has become so drug resistant now ... options to treat this serious disease. ,Doctors prescribe ... ofloxacin, and levofloxacin) as a treatment for the disease. ... and Prevention (CDC) says that the sexual disorder-that affects ...
... are now looking at lactate with a much more ... the brain in the immediate //hours after a traumatic ... they are right, it could change how emergency room ... injuries in the first critical hours after injury. ...
... Viagra, Cialis, and Levitra are the answer to their ... a new report from Harvard Medical School, these pills ... pressures that frequently accompany erectile dysfunction (ED). ... man is feeling sexual desire for his partner. If ...
Cached Medicine News:Health News:Hormone Replacement Therapy – To Choose Or No 2Health News:HIV Experts Criticize Australian PM's Suggestion for Ban on Entry of HIV-infected 2Health News:Physicists Unite To Develop Anthrax Detection Method 2Health News:Physicists Unite To Develop Anthrax Detection Method 3Health News:Physicists Unite To Develop Anthrax Detection Method 4Health News:Scientists Concerned About Gonorrhea’s Drug Resistanc 2Health News:Study Challenges Conventional Treatment of Traumatic Brain Injury 2
... HEXON Illumination System provides the bright, ... with one remarkable difference: HEXON utilizes ... more efficient source of high quality ... a color consistency which is well ...
... handpieces, used for endophotocoagulation indications, include ... gauge, and illuminating models. The full ... with uncompromised laser treatment of intravitreal ... cables that are flexible and convenient ...
The EL401 Manual Plate/Strip Washer accommodates all 96-well microplates and microwell strips. The unique alignment mechanism allows quick and accurate positioning of the 8- or 12-channel manifold ab...
Anterior chamber protein meter. Can be used for both slit and flare measurement....
Medicine Products: